These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 11862379)
41. Behavioral effects and pharmacokinetics of gamma-hydroxybutyrate (GHB) precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) in baboons. Goodwin AK; Brown PR; Jansen EE; Jakobs C; Gibson KM; Weerts EM Psychopharmacology (Berl); 2009 Jun; 204(3):465-76. PubMed ID: 19198808 [TBL] [Abstract][Full Text] [Related]
42. Blockade of the discriminative stimulus effects of gamma-hydroxybutyric acid (GHB) by the GHB receptor antagonist NCS-382. Colombo G; Agabio R; Bourguignon J; Fadda F; Lobina C; Maitre M; Reali R; Schmitt M; Gessa GL Physiol Behav; 1995 Sep; 58(3):587-90. PubMed ID: 8587968 [TBL] [Abstract][Full Text] [Related]
43. Gamma-hydroxybutyrate (GHB): a newer drug of abuse. O'Connell T; Kaye L; Plosay JJ Am Fam Physician; 2000 Dec; 62(11):2478-83. PubMed ID: 11130233 [TBL] [Abstract][Full Text] [Related]
44. Residual social, memory and oxytocin-related changes in rats following repeated exposure to γ-hydroxybutyrate (GHB), 3,4-methylenedioxymethamphetamine (MDMA) or their combination. van Nieuwenhuijzen PS; Long LE; Hunt GE; Arnold JC; McGregor IS Psychopharmacology (Berl); 2010 Dec; 212(4):663-74. PubMed ID: 20730418 [TBL] [Abstract][Full Text] [Related]
45. Evaluation of the discriminative stimulus and reinforcing effects of gammahydroxybutyrate (GHB). Beardsley PM; Balster RL; Harris LS Psychopharmacology (Berl); 1996 Oct; 127(4):315-22. PubMed ID: 8923566 [TBL] [Abstract][Full Text] [Related]
47. [Withdrawal syndrome after abuse of GHB (Gamma-Hydroxybutyrate) and its physiological precursors - its relevance for child and adolescent psychiatrists]. Zepf FD; Holtmann M; Duketis E; Maier J; Radeloff D; Schirman S; Wagner A; Poustka F; Wöckel L Z Kinder Jugendpsychiatr Psychother; 2009 Sep; 37(5):413-20. PubMed ID: 19739059 [TBL] [Abstract][Full Text] [Related]
48. GHB: an important pharmacologic and clinical update. Okun MS; Boothby LA; Bartfield RB; Doering PL J Pharm Pharm Sci; 2001; 4(2):167-75. PubMed ID: 11466174 [TBL] [Abstract][Full Text] [Related]
53. Possible long-term effects of γ-hydroxybutyric acid (GHB) due to neurotoxicity and overdose. van Amsterdam JG; Brunt TM; McMaster MT; Niesink RJ Neurosci Biobehav Rev; 2012 Apr; 36(4):1217-27. PubMed ID: 22342779 [TBL] [Abstract][Full Text] [Related]
54. Use of GHB compounds by HIV-positive individuals. Camacho A; Matthews SC; Dimsdale JE Am J Addict; 2004; 13(2):120-7. PubMed ID: 15204663 [TBL] [Abstract][Full Text] [Related]
55. Fatality due to gamma-hydroxybutyric acid (GHB) and heroin intoxication. Ferrara SD; Tedeschi L; Frison G; Rossi A J Forensic Sci; 1995 May; 40(3):501-4. PubMed ID: 7782758 [TBL] [Abstract][Full Text] [Related]
56. Gamma-hydroxybutyrate detoxification by titration and tapering. de Jong CA; Kamal R; Dijkstra BA; de Haan HA Eur Addict Res; 2012; 18(1):40-5. PubMed ID: 22142784 [TBL] [Abstract][Full Text] [Related]
57. A review of pharmacology of NCS-382, a putative antagonist of gamma-hydroxybutyric acid (GHB) receptor. Castelli MP; Pibiri F; Carboni G; Piras AP CNS Drug Rev; 2004; 10(3):243-60. PubMed ID: 15492774 [TBL] [Abstract][Full Text] [Related]
58. [Gamma-hydroxybutyric acid--significance for anesthesia and intensive care medicine?]. Kleinschmidt S; Mertzlufft F Anasthesiol Intensivmed Notfallmed Schmerzther; 1995 Nov; 30(7):393-402. PubMed ID: 8562713 [TBL] [Abstract][Full Text] [Related]
59. Absence of effects of corticosterone given at 22 days. Howard E Dev Psychobiol; 1976 Jan; 9(1):25-9. PubMed ID: 1254103 [TBL] [Abstract][Full Text] [Related]
60. The clinical development of gamma-hydroxybutyrate (GHB). Wedin GP; Hornfeldt CS; Ylitalo LM Curr Drug Saf; 2006 Jan; 1(1):99-106. PubMed ID: 18690919 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]